2021-04-12
Published Date
Life Science
Industry
107
Pages
The latest study on Gastrointestinal Therapeutics Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Gastrointestinal Therapeutics Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Gastrointestinal Therapeutics and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Novartis
AstraZeneca
Amgen
Takeda
Eli Lilly
GlaxoSmithKline
Johnson & Johnson
F. Hoffmann-La Roche
Shire Pharmaceuticals
Allergan
Merck
Tillotts Pharma
AbbVie
Pfizer
Procter & Gamble
Gastrointestinal Therapeutics Market Analysis By Type Segment:
Oral
Parenteral
Gastrointestinal Therapeutics Market Analysis By Application Segment:
IBD
Irritable Bowel Syndrome (IBS)
The Gastrointestinal Therapeutics Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Gastrointestinal Therapeutics Report:
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Gastrointestinal Therapeutics Market:
Gastrointestinal Therapeutics market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
Detailed information about Key Top Competitors in the Global Gastrointestinal Therapeutics Market
What is the expected Market size and growth rate of the Gastrointestinal Therapeutics market for the forecast period
Where is the largest and fastest growing market for Gastrointestinal Therapeutics market
How does the market relate to the overall economy, demography and other similar markets
What forces will shape the market going forward
Can I include additional segmentation / market segmentation
Gastrointestinal Therapeutics market global report answers all these questions and many more.
The study objectives are:
To analyze and research the Gastrointestinal Therapeutics Market status and future forecast.
To present the key Gastrointestinal Therapeutics Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Frequently Asked Questions - FAQ:
How big is the opportunity for the Gastrointestinal Therapeutics market
Which are the recent industry development that can be implemented to generate additional revenue streams
Who are the major players operating in the Gastrointestinal Therapeutics market Which companies are the front runners
What are the major end-use industries of Gastrointestinal Therapeutics market
Feel free to contact us for Customisation, Request For Free Sample, Ask for discount
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Gastrointestinal Therapeutics Market Size Growth Rate by Type (2016-2027)
1.4.2 Oral
1.4.3 Parenteral
1.5 Market by Application
1.5.1 Global Gastrointestinal Therapeutics Market Share by Application (2016-2027)
1.5.2 IBD
1.5.3 Irritable Bowel Syndrome (IBS)
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Gastrointestinal Therapeutics Market Size
2.2 Gastrointestinal Therapeutics Growth Trends by Regions
2.2.1 Gastrointestinal Therapeutics Market Size by Regions (2016-2027)
2.2.2 Gastrointestinal Therapeutics Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Gastrointestinal Therapeutics Market Size by Manufacturers
3.1.1 Global Gastrointestinal Therapeutics Revenue by Manufacturers (2016-2020)
3.1.2 Global Gastrointestinal Therapeutics Revenue Market Share by Manufacturers (2016-2020)
3.1.3 Global Gastrointestinal Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Gastrointestinal Therapeutics Key Players Head office and Area Served
3.3 Key Players Gastrointestinal Therapeutics Product/Solution/Service
3.4 Date of Enter into Gastrointestinal Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Gastrointestinal Therapeutics Market Size by Type (2016-2020)
4.2 Global Gastrointestinal Therapeutics Market Size by Application (2016-2020)
5 United States
5.1 United States Gastrointestinal Therapeutics Market Size (2016-2020)
5.2 Gastrointestinal Therapeutics Key Players in United States
5.3 United States Gastrointestinal Therapeutics Market Size by Type
5.4 United States Gastrointestinal Therapeutics Market Size by Application
6 Europe
6.1 Europe Gastrointestinal Therapeutics Market Size (2016-2020)
6.2 Gastrointestinal Therapeutics Key Players in Europe
6.3 Europe Gastrointestinal Therapeutics Market Size by Type
6.4 Europe Gastrointestinal Therapeutics Market Size by Application
7 China
7.1 China Gastrointestinal Therapeutics Market Size (2016-2020)
7.2 Gastrointestinal Therapeutics Key Players in China
7.3 China Gastrointestinal Therapeutics Market Size by Type
7.4 China Gastrointestinal Therapeutics Market Size by Application
8 Japan
8.1 Japan Gastrointestinal Therapeutics Market Size (2016-2020)
8.2 Gastrointestinal Therapeutics Key Players in Japan
8.3 Japan Gastrointestinal Therapeutics Market Size by Type
8.4 Japan Gastrointestinal Therapeutics Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Gastrointestinal Therapeutics Market Size (2016-2020)
9.2 Gastrointestinal Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Gastrointestinal Therapeutics Market Size by Type
9.4 Southeast Asia Gastrointestinal Therapeutics Market Size by Application
10 India
10.1 India Gastrointestinal Therapeutics Market Size (2016-2020)
10.2 Gastrointestinal Therapeutics Key Players in India
10.3 India Gastrointestinal Therapeutics Market Size by Type
10.4 India Gastrointestinal Therapeutics Market Size by Application
11 Central & South America
11.1 Central & South America Gastrointestinal Therapeutics Market Size (2016-2020)
11.2 Gastrointestinal Therapeutics Key Players in Central & South America
11.3 Central & South America Gastrointestinal Therapeutics Market Size by Type
11.4 Central & South America Gastrointestinal Therapeutics Market Size by Application
12 International Players Profiles
12.1 AbbVie
12.1.1 AbbVie Company Details
12.1.2 Company Description and Business Overview
12.1.3 Gastrointestinal Therapeutics Introduction
12.1.4 AbbVie Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.1.5 AbbVie Recent Development
12.2 Allergan
12.2.1 Allergan Company Details
12.2.2 Company Description and Business Overview
12.2.3 Gastrointestinal Therapeutics Introduction
12.2.4 Allergan Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.2.5 Allergan Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Company Details
12.3.2 Company Description and Business Overview
12.3.3 Gastrointestinal Therapeutics Introduction
12.3.4 Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.3.5 Johnson & Johnson Recent Development
12.4 Takeda
12.4.1 Takeda Company Details
12.4.2 Company Description and Business Overview
12.4.3 Gastrointestinal Therapeutics Introduction
12.4.4 Takeda Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.4.5 Takeda Recent Development
12.5 Novartis
12.5.1 Novartis Company Details
12.5.2 Company Description and Business Overview
12.5.3 Gastrointestinal Therapeutics Introduction
12.5.4 Novartis Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.5.5 Novartis Recent Development
12.6 Pfizer
12.6.1 Pfizer Company Details
12.6.2 Company Description and Business Overview
12.6.3 Gastrointestinal Therapeutics Introduction
12.6.4 Pfizer Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.6.5 Pfizer Recent Development
12.7 Merck
12.7.1 Merck Company Details
12.7.2 Company Description and Business Overview
12.7.3 Gastrointestinal Therapeutics Introduction
12.7.4 Merck Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.7.5 Merck Recent Development
12.8 F. Hoffmann-La Roche
12.8.1 F. Hoffmann-La Roche Company Details
12.8.2 Company Description and Business Overview
12.8.3 Gastrointestinal Therapeutics Introduction
12.8.4 F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.8.5 F. Hoffmann-La Roche Recent Development
12.9 Eli Lilly
12.9.1 Eli Lilly Company Details
12.9.2 Company Description and Business Overview
12.9.3 Gastrointestinal Therapeutics Introduction
12.9.4 Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.9.5 Eli Lilly Recent Development
12.10 AstraZeneca
12.10.1 AstraZeneca Company Details
12.10.2 Company Description and Business Overview
12.10.3 Gastrointestinal Therapeutics Introduction
12.10.4 AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2016-2020)
12.10.5 AstraZeneca Recent Development
12.11 Procter & Gamble
12.12 Tillotts Pharma
12.13 Shire Pharmaceuticals
12.14 GlaxoSmithKline
12.15 Amgen
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
List of Tables and Figures
List of Tables and Figures
Table Gastrointestinal Therapeutics Key Market Segments
Table Key Players Gastrointestinal Therapeutics Covered
Table Global Gastrointestinal Therapeutics Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Gastrointestinal Therapeutics Market Size Market Share by Type 2016-2027
Figure Oral Figures
Table Key Players of Oral
Figure Parenteral Figures
Table Key Players of Parenteral
Table Global Gastrointestinal Therapeutics Market Size Growth by Application 2016-2027 (Million US$)
Figure IBD Case Studies
Figure Irritable Bowel Syndrome (IBS) Case Studies
Figure Gastrointestinal Therapeutics Report Years Considered
Table Global Gastrointestinal Therapeutics Market Size 2016-2027 (Million US$)
Figure Global Gastrointestinal Therapeutics Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Gastrointestinal Therapeutics Market Size by Regions 2016-2027 (Million US$)
Table Global Gastrointestinal Therapeutics Market Size by Regions 2016-2020 (Million US$)
Table Global Gastrointestinal Therapeutics Market Share by Regions 2016-2020
Figure Global Gastrointestinal Therapeutics Market Share by Regions 2016-2020
Figure Global Gastrointestinal Therapeutics Market Share by Regions 2020
Table Market Top Trends
Table Global Gastrointestinal Therapeutics Revenue by Manufacturers (2016-2020) (Million US$)
Table Global Gastrointestinal Therapeutics Market Share by Manufacturers (2016-2020)
Figure Global Gastrointestinal Therapeutics Market Share by Manufacturers in 2020
Table Global Gastrointestinal Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Gastrointestinal Therapeutics Product/Solution/Service
Table Date of Enter into Gastrointestinal Therapeutics Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Global Gastrointestinal Therapeutics Market Size Share by Type (2016-2020)
Figure Global Gastrointestinal Therapeutics Market Size Market Share by Type (2016-2020)
Table Global Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Global Gastrointestinal Therapeutics Market Size Share by Application (2016-2020)
Figure Global Gastrointestinal Therapeutics Market Size Market Share by Application (2016-2020)
Figure Global Gastrointestinal Therapeutics Revenue Market Share by Application in 2020
Figure United States Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table United States Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table United States Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table United States Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table United States Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table United States Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table United States Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Figure Europe Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table Europe Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table Europe Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table Europe Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Europe Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table Europe Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Europe Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Figure China Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table China Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table China Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table China Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table China Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table China Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table China Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Figure Japan Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table Japan Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table Japan Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table Japan Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Japan Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table Japan Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Japan Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Figure Southeast Asia Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table Southeast Asia Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table Southeast Asia Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table Southeast Asia Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Figure India Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table India Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table India Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table India Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table India Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table India Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table India Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Figure Central & South America Gastrointestinal Therapeutics Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Gastrointestinal Therapeutics Revenue (2020-2020) (Million US$)
Table Central & South America Key Players Gastrointestinal Therapeutics Market Share (2020-2020)
Table Central & South America Gastrointestinal Therapeutics Market Size by Type (2016-2020) (Million US$)
Table Central & South America Gastrointestinal Therapeutics Market Share by Type (2016-2020)
Table Central & South America Gastrointestinal Therapeutics Market Size by Application (2016-2020) (Million US$)
Table Central & South America Gastrointestinal Therapeutics Market Share by Application (2016-2020)
Table AbbVie Company Details
Table AbbVie Revenue in Gastrointestinal Therapeutics Business (2016-2020) (Million US$)
Figure AbbVie Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table AbbVie Recent Development
Table Allergan Company Details
Table Allergan Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Allergan Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Allergan Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Johnson & Johnson Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Johnson & Johnson Recent Development
Table Takeda Company Details
Table Takeda Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Takeda Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Takeda Recent Development
Table Novartis Company Details
Table Novartis Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Novartis Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Novartis Recent Development
Table Pfizer Company Details
Table Pfizer Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Pfizer Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Pfizer Recent Development
Table Merck Company Details
Table Merck Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Merck Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Merck Recent Development
Table F. Hoffmann-La Roche Company Details
Table F. Hoffmann-La Roche Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure F. Hoffmann-La Roche Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table F. Hoffmann-La Roche Recent Development
Table Eli Lilly Company Details
Table Eli Lilly Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure Eli Lilly Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table Eli Lilly Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Gastrointestinal Therapeutics Business (2016-2020)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Gastrointestinal Therapeutics Business (2016-2020)
Table AstraZeneca Recent Development
Table Procter & Gamble Company Details
Table Tillotts Pharma Company Details
Table Shire Pharmaceuticals Company Details
Table GlaxoSmithKline Company Details
Table Amgen Company Details
Table Global Gastrointestinal Therapeutics Market Size by Regions (Million US$) 2021-2027
Figure Global Gastrointestinal Therapeutics Market Size Share by Regions (2021-2027)
Figure Global Gastrointestinal Therapeutics Market Size Share by Regions in 2027
Figure United States Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Europe Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure China Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Japan Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure India Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Gastrointestinal Therapeutics Market Size Forecast (2021-2027)(Million USD)
Table Global Gastrointestinal Therapeutics Market Size by Product (2021-2027) (Million US$)
Figure Global Gastrointestinal Therapeutics Market Size by Product (2021-2027)
Figure Global Gastrointestinal Therapeutics Market Size by Product in 2027
Table Global Gastrointestinal Therapeutics Market Size by Application (2021-2027) (Million US$)
Figure Global Gastrointestinal Therapeutics Market Size by Application (2021-2027)
Figure Global Gastrointestinal Therapeutics Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources